These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 5303389)
21. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. Boorse GC; Denver RJ Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023 [TBL] [Abstract][Full Text] [Related]
22. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells. Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211 [TBL] [Abstract][Full Text] [Related]
23. Release of corticotropin and corticotropin-releasing factors from rat posterior pituitary in vitro. Bény JL; Baertschi AJ Neuroendocrinology; 1980; 30(2):108-12. PubMed ID: 6243758 [TBL] [Abstract][Full Text] [Related]
24. Corticotropin-releasing factor is a downstream mediator of the beta-melanocyte-stimulating hormone-induced anorexigenic pathway in chicks. Kamisoyama H; Honda K; Saneyasu T; Sugahara K; Hasegawa S Neurosci Lett; 2009 Jul; 458(3):102-5. PubMed ID: 19393716 [TBL] [Abstract][Full Text] [Related]
25. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2. Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478 [TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing factor (CRF) is involved in the acute anorexic effect of alpha-melanocyte-stimulating hormone: a study using CRF-deficient mice. Kawashima S; Sakihara S; Kageyama K; Nigawara T; Suda T Peptides; 2008 Dec; 29(12):2169-74. PubMed ID: 18930089 [TBL] [Abstract][Full Text] [Related]
27. Studies on the chemical nature of bioactive CRF in testis and other peripheral tissues. Audhya T; Hollander CS Trans Assoc Am Physicians; 1987; 100():62-9. PubMed ID: 3502663 [No Abstract] [Full Text] [Related]
28. Studies on the nature of corticotrophin releasing hormone and its partial purification from porcine hypothalami. Cooper DM; Synetos D; Christie RB; Schulster D J Endocrinol; 1976 Oct; 71(1):171-2. PubMed ID: 1086337 [No Abstract] [Full Text] [Related]
33. [Methods for the analysis of the corticotropin releasing factor]. Kumahara Y; Tsuchiya H Nihon Rinsho; 1986 Mar; 44(3):497-507. PubMed ID: 3525892 [No Abstract] [Full Text] [Related]
34. Studies on peptides. CXXIII. Preparations of nine peptide fragments for the synthesis of human corticotropin releasing factor (hCRF). Fujii N; Nomizu M; Akaji K; Shimokura M; Katakura S; Yajima H Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4786-96. PubMed ID: 6335979 [No Abstract] [Full Text] [Related]
35. Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit. Bale TL; Chen A Endocrinology; 2012 Jun; 153(6):2556-61. PubMed ID: 22492308 [No Abstract] [Full Text] [Related]
36. [Isolation of CRF from the rat hypothalamus and CRF action of synthetic peptides]. Tanaka A; Nakamura M Saishin Igaku; 1968 Apr; 23(4):829-31. PubMed ID: 5303389 [No Abstract] [Full Text] [Related]